News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,404 Results
Type
Article (2452)
Company Profile (39)
Press Release (35913)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14155)
Career Advice (77)
Deals (2087)
Drug Delivery (9)
Drug Development (4119)
Employer Resources (10)
FDA (433)
Job Trends (770)
News (20195)
Policy (1054)
Tag
Academia (144)
Allergies (6)
Alliances (3482)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (18)
Approvals (435)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (481)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (150)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (16)
Cell therapy (49)
Cervical cancer (2)
Clinical research (3201)
Collaboration (95)
Compensation (51)
COVID-19 (180)
CRISPR (8)
C-suite (31)
Cystic fibrosis (2)
Data (123)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (465)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4265)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6080)
Executive appointments (100)
FDA (482)
Funding (79)
Gene editing (15)
Gene therapy (22)
GLP-1 (61)
Government (149)
Guidances (1)
Healthcare (706)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (993)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (40)
Leadership (1)
Legal (212)
Liver cancer (6)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (20)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1169)
Metabolic disorders (34)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (95)
NextGen: Class of 2025 (354)
Non-profit (153)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5680)
Pharmaceutical (5)
Phase I (1381)
Phase II (1611)
Phase III (848)
Pipeline (85)
Policy (12)
Postmarket research (30)
Preclinical (600)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (24)
Real estate (421)
Recruiting (5)
Regulatory (810)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (12)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (16)
Last 7 days (92)
Last 30 days (259)
Last 365 days (2568)
2025 (875)
2024 (2613)
2023 (2863)
2022 (3760)
2021 (4066)
2020 (3488)
2019 (2076)
2018 (1562)
2017 (1796)
2016 (1627)
2015 (1835)
2014 (1369)
2013 (1188)
2012 (1398)
2011 (1335)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (15)
Asia (1874)
Australia (298)
California (884)
Canada (138)
China (41)
Colorado (21)
Connecticut (10)
Delaware (4)
Europe (3859)
Florida (44)
Georgia (6)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (8)
Kansas (12)
Maryland (26)
Massachusetts (319)
Michigan (9)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (72)
New York (51)
North Carolina (92)
Northern California (384)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (54)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (373)
Tennessee (2)
Texas (75)
United States (1826)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
38,404 Results for "axol bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Axol Bioscience Acquires Phenocell to Advance Human Disease Models
October 21, 2024
·
1 min read
Genetown
Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.
June 7, 2023
·
3 min read
Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes to Help Improve Drug Discovery
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
June 7, 2022
·
3 min read
Genetown
Axol Bioscience Raises £3.2 million GBP (c. $4.2 million USD)
Axol Bioscience Ltd. announced that it has raised £3.2 million GBP in the extension of its previous funding round, bringing the total raised to £7 million GBP.
April 7, 2022
·
2 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Crown Bioscience and NEXT Oncology Cement Partnership Extension
May 1, 2025
·
3 min read
Press Releases
Solid Biosciences to Participate at The Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Skye Bioscience to Participate in May Investment and Medical Conferences
April 30, 2025
·
3 min read
Press Releases
Arizona Biosciences Set Record Highs in Research Funding, Show Increasing Competitiveness
April 23, 2025
·
3 min read
1 of 3,841
Next
